These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 28886115)
21. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer. Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA Regulation of Androgen Receptor in Castration-Resistant Prostate Cancer: Premises, Promises, and Potentials. Ebrahimi S; Hashemy SI; Sahebkar A; Aghaee Bakhtiari SH Curr Mol Pharmacol; 2021 Oct; 14(4):559-569. PubMed ID: 33357209 [TBL] [Abstract][Full Text] [Related]
23. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy. Wan X; Pu H; Huang W; Yang S; Zhang Y; Kong Z; Yang Z; Zhao P; Li A; Li T; Li Y Oncotarget; 2016 Aug; 7(32):51284-51300. PubMed ID: 27323416 [TBL] [Abstract][Full Text] [Related]
24. The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway. Wang L; Song G; Chang X; Tan W; Pan J; Zhu X; Liu Z; Qi M; Yu J; Han B Oncogene; 2015 Sep; 34(36):4735-45. PubMed ID: 25500540 [TBL] [Abstract][Full Text] [Related]
25. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer. Cai Z; Chen W; Zhang J; Li H Int Urol Nephrol; 2018 Oct; 50(10):1753-1764. PubMed ID: 30128923 [TBL] [Abstract][Full Text] [Related]
26. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model. Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672 [TBL] [Abstract][Full Text] [Related]
27. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
28. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
29. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression. Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis. Chen WY; Tsai YC; Siu MK; Yeh HL; Chen CL; Yin JJ; Huang J; Liu YN Oncogene; 2017 Nov; 36(45):6213-6224. PubMed ID: 28692046 [TBL] [Abstract][Full Text] [Related]
31. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity. Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728 [TBL] [Abstract][Full Text] [Related]
32. MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways. Ebron JS; Shankar E; Singh J; Sikand K; Weyman CM; Gupta S; Lindner DJ; Liu X; Campbell MJ; Shukla GC Cancer Res; 2019 Apr; 79(8):1844-1856. PubMed ID: 30808676 [TBL] [Abstract][Full Text] [Related]
33. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557 [TBL] [Abstract][Full Text] [Related]
34. Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer. Zheng D; Gui B; Gray KP; Tinay I; Rafiei S; Huang Q; Sweeney CJ; Kibel AS; Jia L Oncogene; 2016 Sep; 35(36):4807-15. PubMed ID: 26876202 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1. Lu K; Liu C; Tao T; Zhang X; Zhang L; Sun C; Wang Y; Chen S; Xu B; Chen M FEBS Lett; 2015 Jun; 589(13):1485-90. PubMed ID: 25936765 [TBL] [Abstract][Full Text] [Related]
36. The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression. Liu H; Wu Z; Zhou H; Cai W; Li X; Hu J; Gao L; Feng T; Wang L; Peng X; Qi M; Liu L; Han B Neoplasia; 2019 Aug; 21(8):765-776. PubMed ID: 31238254 [TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1. Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617 [TBL] [Abstract][Full Text] [Related]
39. Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice. Wu M; Kim SH; Datta I; Levin A; Dyson G; Li J; Kaypee S; Swamy MM; Gupta N; Kwon HJ; Menon M; Kundu TK; Reddy GP Oncotarget; 2015 Mar; 6(8):6136-50. PubMed ID: 25704883 [TBL] [Abstract][Full Text] [Related]
40. Microdissecting the role of microRNAs in the pathogenesis of prostate cancer. Ayub SG; Kaul D; Ayub T Cancer Genet; 2015 Jun; 208(6):289-302. PubMed ID: 26004033 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]